Julie Gamradt Featured in WSJ
Outreach program manager/augmentative and alternative communication specialist at the Communication Aids and Systems Clinic (CASC) and Communication Development Program (CDP) at UW-Madison's Waisman Center.
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Outreach program manager/augmentative and alternative communication specialist at the Communication Aids and Systems Clinic (CASC) and Communication Development Program (CDP) at UW-Madison's Waisman Center.
Over 600 people attended the Friends of the Waisman Center Second Annual Films in the Field on Saturday, August 13, 2005 in the athletic fields adjacent to the Waisman Center.
The Friends reception took place on Tuesday, August 9, 2005 from 4:00 – 5:00 p.m. in the 8th floor Ziemann Suite.
In an effort to develop new techniques to repair and protect the nervous system in multiple sclerosis patients, including the use of human stem cells, the National Multiple Sclerosis Society has awarded $3.4 million to a team of UW-Madison scientists.
Boosting levels of two critical proteins that normally shut down during Huntington's disease, researchers at UW-Madison and the Cold Spring Harbor Laboratory have cured fruit flies of the genetic, neurodegenerative condition.
Addressing a persistent debate in the field of dyslexia research, scientists have disproved the popular theory that deficits in certain visual processes cause the spelling and reading woes commonly suffered by people with dyslexia.
For a young child whose mother is imprisoned, life's prospects are predictably grim.
Like harried parents anywhere, many faculty, staff and students at UW-Madison need good quality, affordable and flexible child care.
At a meeting of stem cell researchers in Madison today (April 26), UW-Madison professor of anatomy and neurology Clive Svendsen announced the establishment of a new regenerative medicine program and an interdisciplinary postdoctoral training program that will advance stem cell research across the university.
Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the UW-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.